APA (7th ed.) Citation

Cohn, D. M., Aygören‐Pürsün, E., Bernstein, J. A., Farkas, H., Lumry, W. R., Maurer, M., . . . Riedl, M. A. (2023). Evaluation of patient‐reported outcome measures for on‐demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat. Clinical & Translational Allergy, 13(9), 1. https://doi.org/10.1002/clt2.12288

Chicago Style (17th ed.) Citation

Cohn, Danny M., et al. "Evaluation of Patient‐reported Outcome Measures for On‐demand Treatment of Hereditary Angioedema Attacks And design of KONFIDENT, a Phase 3 Trial of Sebetralstat." Clinical & Translational Allergy 13, no. 9 (2023): 1. https://doi.org/10.1002/clt2.12288.

MLA (9th ed.) Citation

Cohn, Danny M., et al. "Evaluation of Patient‐reported Outcome Measures for On‐demand Treatment of Hereditary Angioedema Attacks And design of KONFIDENT, a Phase 3 Trial of Sebetralstat." Clinical & Translational Allergy, vol. 13, no. 9, 2023, p. 1, https://doi.org/10.1002/clt2.12288.